<DOC>
	<DOCNO>NCT00204529</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety adjuvant treatment pegylated interferon-α-2a ( PEG-IFN ) vs. 'low dose ' interferon-α-2a patient malignant melanoma stage IIA ( T3a ) - IIIB . A total 880 randomize three month first surgical management melanoma either : PEG-IFN-α-2a low-dose interferon-α-2a .</brief_summary>
	<brief_title>Pegylated Interferon-alpha-2a Patients With Malignant Melanoma Stage IIA-IIIB</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<criteria>Histologically proven cutaneous melanoma ≥ 18 year age &lt; 75 year age Have confirm stage IIa ( T3a ) , IIB , IIC , IIIA IIIB ( AJCC 2002 ) melanoma ( lymph node stag either per sentinel node biopsy elective lymph node dissection ) Have Karnofsky performance status ≥ 80 % Negative pregnancy test Start therapy within three month surgery Informed consent Pregnant lactate woman Unwillingness inability employ effective barrier method birth control throughout study 3 month end treatment female male patient Mucous membrane ocular melanoma Any evidence distant metastasis ( CTscan brain , Chest X ray CT , abdominal ultrasound CT ultrasound regional lymph node screen ) Patients receive chemotherapy vaccine melanoma Patients tumor progression previous adjuvant interferon therapy within three month termination interferon therapy ( patient previously receive adjuvant interferon therapy another tumor stage without disease progression may include ) History malignancy within last ten year ( except basal cell carcinoma squamous cell carcinoma skin carcinoma situ cervix ) Patients severe cardiac disease ( e.g . NYHA Functional Class III IV , myocardial infarction within 6 month , ventricular tachyarrhythmias require ongoing treatment , unstable angina ) , severe liver disease severe renal disease . ALAT ASAT &gt; 2 x ULN Bilirubin &gt; 2 x ULN Creatinine &gt; 2 x ULN Patients history depression psychiatric diseases require hospitalisation Patients seizure disorder require anticonvulsant therapy Any follow abnormal baseline hematologic/laboratory value : Hb &lt; 10g/dl WBC &lt; 3.0 x 109 /l Platelets &lt; 100x109/l Neutrophils &lt; 1.5 x 109/l History presence autoimmune disease ( i.e . autoimmune hepatitis , thyroid autoimmune dysfunction , systemic lupus erythematodes ) Unwilling unable comply requirement protocol duration study Known infection HBV , HCV , HIV Evidence allergy hypersensitivity IFN pegylated interferon Thyroid disease poorly control prescribed medication Systemic corticosteroid therapy reason ( &gt; 1 month )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>malignant melanoma</keyword>
	<keyword>adjuvant therapy</keyword>
	<keyword>Adjuvants , Immunologic</keyword>
</DOC>